Skip to main content
SpringerLink
Log in

Malignant Phonic Tics

  • Chapter
  • First Online:
Movement Disorder Emergencies

Part of the book series: Current Clinical Neurology ((CCNEU))

  • 1806 Accesses

Abstract

Phonic tics are typically associated with motor tics and the combination usually suggests the diagnosis of Tourette syndrome. Although phonic tics are often mild, in some cases they may be severe and disabling. In addition to causing vocal cord and throat irritation, coprolalia can be socially isolating and lead to adversarial and even legal difficulties for the affected individual. When such “malignant phonic tics” fail to improve with anti-dopaminergic drugs, botulinum toxin treatment or even deep brain stimulation may be required.

This chapter contains video segments that can be found on the accompanying DVD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kurlan R. Clinical practice. Tourette’s Syndrome. N Engl J Med. 2010;363(24):2332–8.

    Article  PubMed  CAS  Google Scholar 

  2. Jankovic J, Kurlan R. Tourette Syndrome: evolving concepts. Mov Disord. 2011;26(6):1149–56. doi:10.1002/mds.23618. Epub 2011 Apr 11.

    Article  PubMed  Google Scholar 

  3. Jankovic J (1997) Phenomenology and classification of tics. In: Jankovic J (ed) Tourette ­syndrome. Neurol CI N Am, vol 15. WB Saunders, Philadelphia. pp 267–275.

    Google Scholar 

  4. Jankovic J. Tourette’s syndrome. N Engl J Med. 2001;345:1184–92.

    Article  PubMed  CAS  Google Scholar 

  5. Leckman J. Tourette’s syndrome. Lancet. 2002;360:1577–86.

    Article  PubMed  Google Scholar 

  6. The Tourette Syndrome Classification Study Group. Definitions and classification of tic disorders. Arch Neurol. 1993;50:1013–6.

    Article  Google Scholar 

  7. Freeman RD, Zinner SH, Müller-Vahl K, et al. Coprophenomena in Tourette syndrome. Dev Med Child Neurol. 2009;51:218–27.

    Article  PubMed  Google Scholar 

  8. Jankovic J, Kwak C, Frankoff R. Tourette syndrome and the law. J Neuropsychiatry Clin Neurosci. 2006;18:86–95.

    Article  PubMed  Google Scholar 

  9. Krauss JK, Jankovic J. Severe motor tics causing cervical myelopathy in Tourette’s syndrome. Mov Disord. 1996;11:563–6.

    Article  PubMed  CAS  Google Scholar 

  10. Jankovic J, Sekula SL, Milas D. Dermatological manifestations of Tourette’s syndrome and obsessive-compulsive disorder. Arch Dermatol. 1998;134:113–4.

    Article  PubMed  CAS  Google Scholar 

  11. Cheung MY, Shahed J, Jankovic J. Malignant Tourette syndrome. Mov Disord. 2007;22:1743–50.

    Article  PubMed  Google Scholar 

  12. Scott B, Jankovic J, Donovan D. Botulinum toxin into vocal cord in the treatment of malignant coprolalia associated with Tourette’s syndrome. Mov Disord. 1996;11:431–3.

    Article  PubMed  CAS  Google Scholar 

  13. Salloway S, Stewart C, Israeli L. Botulinum toxin for refractory vocal tics. Mov Disord. 1996;11:746–8.

    Article  PubMed  CAS  Google Scholar 

  14. Trimble M, Whurr R, Brookes F, Robertson M. Vocal tics in Gilles de la Tourette syndrome treated with botulinum toxin injections. Mov Disord. 1998;13:617–9.

    Article  PubMed  CAS  Google Scholar 

  15. Jeffries K, Schooler C, Schoenbach C, Herscovitch P, Chase T, Braun A. The functional neuroanatomy of Tourette’s syndrome: an FDG PET study III: functional coupling of regional cerebral metabolic rates. Neuropsychopharmacology. 2002;27:92–104.

    Article  PubMed  CAS  Google Scholar 

  16. Albin RL, Mink JW. Recent advances in Tourette syndrome research. Trends Neurosci. 2006;29:175–82.

    Article  PubMed  CAS  Google Scholar 

  17. Pourfar M, Feigin A, Tang CC, et al. Abnormal metabolic brain networks in Tourette ­syndrome. Neurology. 2011;76:944–52.

    Article  PubMed  CAS  Google Scholar 

  18. Lang A. Patient perception of tics and other movement disorders. Neurology. 1991;41:223–8.

    Article  PubMed  CAS  Google Scholar 

  19. Kwak C, Vuong KD, Jankovic J. Premonitory sensory phenomenon in Tourette’s syndrome. Mov Disord. 2003;18:1530–3.

    Article  PubMed  Google Scholar 

  20. Prado HS, Rosario MC, Lee J, et al. Sensory phenomena in obsessive–compulsive disorder and tic disorders: a review of the literature. CNS Spectr. 2008;13:425–32.

    PubMed  Google Scholar 

  21. Kwak C, Hanna P, Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol. 2000;57:1190–3.

    Article  PubMed  CAS  Google Scholar 

  22. Marras C, Andrews D, Sime E, Lang A. Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology. 2001;56:605–10.

    Article  PubMed  CAS  Google Scholar 

  23. Aguirregomozcorta M, Pagonabarraga J, Diaz-Manera J, et al. Efficacy of botulinum toxin in severe Tourette syndrome with dystonic tics involving the neck. Parkinsonism Relat Disord. 2008;14:443–5.

    Article  PubMed  Google Scholar 

  24. Jimenez-Jimenez F, Garcia-Ruiz P. Pharmacological options for the treatment of Tourette’s disorder. Drugs. 2001;61:2207–20.

    Article  PubMed  CAS  Google Scholar 

  25. Jankovic J. Treatment of hyperkinetic movement disorders. Lancet Neurol. 2009;8:844–56.

    Article  PubMed  CAS  Google Scholar 

  26. Shprecher D, Kurlan R. The management of tics. Mov Disord. 2009;24:15–24.

    Article  PubMed  Google Scholar 

  27. Peña MS, Yaltho TC, Jankovic J. Tardive dyskinesia and other movement disorders secondary to aripiprazole. Mov Disord. 2011;26:147–52.

    Article  PubMed  Google Scholar 

  28. Silay Y, Jankovic J. Emerging drugs in Tourette syndrome. Expert Opin Emerg Drugs. 2005;10:365–80.

    Article  PubMed  CAS  Google Scholar 

  29. Kenney C, Hunter C, Mejia N, Jankovic J. Tetrabenazine in the treatment of Tourette ­syndrome. J Ped Neurol. 2007;5:9–13.

    CAS  Google Scholar 

  30. Scahill L, Chappell P, Kim Y, et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry. 2001;158:1067–74.

    Article  PubMed  CAS  Google Scholar 

  31. Gaffney G, Perry P, Lund B, Bever-Stille K, Arndt S, Kuperman S. Risperidone versus clonidine in the treatment of children and adolescents with Tourette’s syndrome. J Am Acad Child Adolesc Psychiatry. 2002;41:330–6.

    Article  PubMed  Google Scholar 

  32. Piacentini J, Woods DW, Scahill L, et al. Behavior therapy for children with Tourette disorder: randomized controlled trial. JAMA. 2010;303:1929–37.

    Article  PubMed  CAS  Google Scholar 

  33. Jankovic J, Albanese A, Atassi MZ, Dolly JO, Hallett M, Mayer N. Botulinum toxin. Therapeutic clinical practice and science. Philadelphia, PA: Saunders (Elsevier); 2009. p. 1–492.

    Google Scholar 

  34. Ackermans L, Duits A, van der Linden C, et al. Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome. Brain. 2011;134:832–44.

    Article  PubMed  Google Scholar 

  35. Martinez-Fernandez R, Zrinzo L, Aviles-Olmos I, et al. Deep brain stimulation for Gilles de la Tourette syndrome: a case series targeting subregions of the globus pallidus internus. Mov Disord. 2011;26(10):1922–30. doi:10.1002/mds.23734.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Parkinson’s Disease Center and Movement Disorders Clinic, Baylor College of Medicine, 6550 Fannin Street, Suite 1801, Houston, TX, 77030, USA

    Joseph Jankovic M.D.

Authors
  1. Joseph Jankovic M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph Jankovic M.D. .

Editor information

Editors and Affiliations

  1. , Neurology, Columbia University Medical Center, West 168th St. Suite 310 710, New York, 10032, USA

    Steven J. Frucht

Electronic Supplementary Material

Movement_Disorders_Emergencies_C17.mov (279,307 KB)

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Jankovic, J. (2013). Malignant Phonic Tics. In: Frucht, S. (eds) Movement Disorder Emergencies. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-835-5_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-835-5_17

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-834-8

  • Online ISBN: 978-1-60761-835-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation